Predictboard ·
🎯 Other
Will the FDA approve retatrutide?

Will the FDA approve retatrutide? — Before Jan 1, 2028

Live
Resolves Jan 1, 2028Kalshi
Volume-weighted avg
84%
No
16%
No (16%)Yes (84%)
Check on Kalshi →
Probability History
Loading...
Market snapshot
Status
Open
Category
Other
Vol 24h
$2k
Liquidity
$4k

Market intelligence

Kalshi currently prices this at 84%. Kalshi has moved down 2pp over the past 7 days.

About this market

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2028, then the market resolves to Yes.

All outcomes · Will the FDA approve retatrutide?

Will the FDA approve retatrutide? — Before Jan 1, 2029
92%
Will the FDA approve retatrutide? — Before Jul 1, 2028
88%
Will the FDA approve retatrutide? — Before Jul 1, 2027
24%
Will the FDA approve retatrutide? — Before Jan 1, 2027
7%
Trade this marketLive prices
Avg probability
84%
probability of YES
Kalshi
84%Check
TGWA
Create Widget
Resolution
Jan 1, 2028
Market is open
Market stats
24h volume$2k
Liquidity$4k
CategoryOther
StatusOpen